Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP527102.RAbAqoG9kJ9teQn3GAjncKlRl35VfvhSC-tu689J_8Hzk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP527102.RAbAqoG9kJ9teQn3GAjncKlRl35VfvhSC-tu689J_8Hzk130_assertion type Assertion NP527102.RAbAqoG9kJ9teQn3GAjncKlRl35VfvhSC-tu689J_8Hzk130_head.
- NP527102.RAbAqoG9kJ9teQn3GAjncKlRl35VfvhSC-tu689J_8Hzk130_assertion description "[Using 8F1, low ERCC1 was correlated with the adenocarcinoma histotype, increased tumor size and clinical stage, high pT and pN category and the presence of metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527102.RAbAqoG9kJ9teQn3GAjncKlRl35VfvhSC-tu689J_8Hzk130_provenance.
- NP527102.RAbAqoG9kJ9teQn3GAjncKlRl35VfvhSC-tu689J_8Hzk130_assertion evidence source_evidence_literature NP527102.RAbAqoG9kJ9teQn3GAjncKlRl35VfvhSC-tu689J_8Hzk130_provenance.
- NP527102.RAbAqoG9kJ9teQn3GAjncKlRl35VfvhSC-tu689J_8Hzk130_assertion SIO_000772 21030862 NP527102.RAbAqoG9kJ9teQn3GAjncKlRl35VfvhSC-tu689J_8Hzk130_provenance.
- NP527102.RAbAqoG9kJ9teQn3GAjncKlRl35VfvhSC-tu689J_8Hzk130_assertion wasDerivedFrom befree-20140225 NP527102.RAbAqoG9kJ9teQn3GAjncKlRl35VfvhSC-tu689J_8Hzk130_provenance.
- NP527102.RAbAqoG9kJ9teQn3GAjncKlRl35VfvhSC-tu689J_8Hzk130_assertion wasGeneratedBy ECO_0000203 NP527102.RAbAqoG9kJ9teQn3GAjncKlRl35VfvhSC-tu689J_8Hzk130_provenance.